Borviz 3.5mg Injection: Effective Medication for Your Needs

Description:

• Class: Proteasome inhibitors.
• Active ingredient: Bortezomib.

Uses:

• Treatment of multiple myeloma.
• Treatment of mantle cell lymphoma.

Administration:

• Administered intravenously in your vein or subcutaneously under the skin.
• Should be given by a qualified healthcare professional experienced in the use of cytotoxic medications.
• Do not self-administer.

Warnings and precautions:

• Do not use if you have severe lung or heart problems.
• Inform your doctor if you are allergic to Borviz 3.5mg Injection and its ingredients.
• Let your physician know if you are suffering from neuropathy, cardiac disorders, severe lung problems, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia, neutropenia, tumour lysis syndrome, hepatic disorders, or diabetes.
• Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light.
• Keep out of sight and reach of children.

Safety advice:

• Pregnancy: unsafe to use during pregnancy unless clearly necessary. Both women of childbearing potential and men must use an effective contraception method during and three months after treatment.
• Breastfeeding: unsafe to use during breastfeeding. Discuss with your physician when it is safe to restart breastfeeding after this treatment.
• Lungs: it is unknown whether Borviz 3.5mg Injection can be given to lung failure patients. Consult your physician if you have any lung diseases.
• Liver: inform your physician before starting this treatment if you have hepatitis infection or liver disease.
• Alcohol: it is unsafe to consume alcohol with this medication.
• Driving: avoid driving or using machinery if you experience side effects like fainting, dizziness, tiredness, or blurred vision.

Side effects:

• Serious: muscle cramps, confusion, visual disturbances, seizures, headache, breathlessness, swelling of feet, changes in heartbeat, high blood pressure, fainting and tiredness, cough and chest tightness.
• Common: pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, reduction in blood cell count, reduced kidney function, shivering, infections, itching and redness, dehydration, stomach problems, difficulty sleeping, anxiety, mood swings, depressed mood.

FAQs:

1. What is Borviz 3.5mg Injection used for?
   • Borviz 3.5mg Injection is mainly indicated to treat mantle cell lymphoma and multiple myeloma.
2. Can I drive while taking Borviz 3.5mg Injection?
   • Borviz 3.5mg Injection may cause dizziness, tiredness, fainting, or blurred vision. Hence, avoid driving and operating heavy machines while this Injection.
3. How is Borviz 3.5mg Injection given?
   • Borviz 3.5mg Injection is administered intravenously in your vein or subcutaneously under the skin by a doctor in a medical facility.
4. Is it safe to handle Borviz 3.5mg Injection while pregnant?
   • No, Pregnant women should not handle Borviz 3.5mg Injection as it contains cytotoxic agents. Using gloves and protective clothing is recommended to prevent skin contact.
5. What class of chemo is Borviz 3.5mg Injection?
   • Borviz 3.5mg Injection is a targeted therapy that belongs to the class of medicines called proteasome inhibitors.
6. Can I take Borviz 3.5mg Injection when I am pregnant?
   • Avoid taking Borviz 3.5mg Injection if you are pregnant, as it can cause harmful effects on the unborn baby. Females should use effective birth control methods during treatment and at least three months after treatment.
7. I am suffering from a hepatitis infection. Can I take Borviz 3.5mg Injection?
   • Borviz 3.5mg Injection should not be used in patients with hepatitis infection because they might have a repeated attack of hepatitis, which can be fatal. If you have a history of hepatitis B infection, your doctor will carefully check you for signs of active hepatitis B.

Fact box:

• Molecule name: Bortezomib.
• Therapeutic class: Antineoplastics agents.
• Pharmacological class: Proteasome inhibitor.
• Indications:
  • Multiple myeloma.
  • Mantle cell lymphoma.

Tags: medical-injection, borviz-injection, pain-relief-injection, pharmaceutical-product, anti-inflammatory-injection